Gene · 1633
Papers2,658
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,658
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The mental health experiences of ethnic minorities in the UK during the Coronavirus pandemic: A qualitative exploration. | Front Public Health | 2022 | 36276403 | PubTator, text mining | PubMed |
| Extracellular Vesicles in Cancer Drug Resistance: Roles, Mechanisms, and Implications. | Adv Sci (Weinh) | 2022 | 36253096 | PubTator, text mining | PubMed |
| Integrating teacher data literacy with TPACK: A self-report study based on a novel framework for teachers' professional development. | Front Psychol | 2022 | 36248455 | PubTator, text mining | PubMed |
| Role of the Tumor Microenvironment in Regulating Pancreatic Cancer Therapy Resistance. | Cells | 2022 | 36230914 | PubTator, text mining | PubMed |
| Targeting E2F Sensitizes Prostate Cancer Cells to Drug-Induced Replication Stress by Promoting Unscheduled CDK1 Activity. | Cancers (Basel) | 2022 | 36230876 | PubTator, text mining | PubMed |
| Identification of Monobenzone as a Novel Potential Anti-Acute Myeloid Leukaemia Agent That Inhibits RNR and Suppresses Tumour Growth in Mouse Xenograft Model. | Cancers (Basel) | 2022 | 36230632 | PubTator, text mining | PubMed |
| Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021. | J Hematol Oncol | 2022 | 36209184 | PubTator, text mining | PubMed |
| A novel immune-related gene signature predicts the prognosis of hepatocellular carcinoma. | Front Oncol | 2022 | 36185203 | PubTator, text mining | PubMed |
| Whole Genome Sequence Analysis of Lactiplantibacillus plantarum Bacteriophage P2. | Pol J Microbiol | 2022 | 36185020 | PubTator, text mining | PubMed |
| AdipoRon and Pancreatic Ductal Adenocarcinoma: a future perspective in overcoming chemotherapy-induced resistance? | Cancer Drug Resist | 2022 | 36176754 | PubTator, text mining | PubMed |
| Metabolic remodeling of pyrimidine synthesis pathway and serine synthesis pathway in human glioblastoma. | Sci Rep | 2022 | 36175487 | PubTator, text mining | PubMed |
| ABAT gene expression associated with the sensitivity of hypomethylating agents in myelodysplastic syndrome through CXCR4/mTOR signaling. | Cell Death Discov | 2022 | 36163180 | PubTator, text mining | PubMed |
| B-Cell Targeted Therapies in Patients with Multiple Sclerosis and Incidence of Headache: A Systematic Review and Meta-Analysis. | J Pers Med | 2022 | 36143259 | PubTator, text mining | PubMed |
| Imaging cellular immunotherapies and immune cell biomarkers: from preclinical studies to patients. | J Immunother Cancer | 2022 | 36137649 | PubTator, text mining | PubMed |
| From Immunotoxins to Suicide Toxin Delivery Approaches: Is There a Clinical Opportunity? | Toxins (Basel) | 2022 | 36136517 | PubTator, text mining | PubMed |
| Impact of conditioning chemotherapy on lymphocyte kinetics and outcomes in LBCL patients treated with CAR T-cell therapy. | Leukemia | 2022 | 36127509 | PubTator, text mining | PubMed |
| An EGFR/HER2-targeted conjugate sensitizes gemcitabine-sensitive and resistant pancreatic cancer through different SMAD4-mediated mechanisms. | Nat Commun | 2022 | 36127339 | PubTator, text mining | PubMed |
| Homoharringtonine demonstrates a cytotoxic effect against triple-negative breast cancer cell lines and acts synergistically with paclitaxel. | Sci Rep | 2022 | 36123435 | PubTator, text mining | PubMed |
| MRI techniques for immunotherapy monitoring. | J Immunother Cancer | 2022 | 36122963 | PubTator, text mining | PubMed |
| Population pharmacokinetic study of pemetrexed in chinese primary advanced non-small cell lung carcinoma patients. | Front Pharmacol | 2022 | 36105185 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1633/papers?page=14